willdate

2065 POSTS 0 COMMENTS

Stress may have clinical implications for heart failure patients

Mental stress and anger may have clinical implications for patients with heart failure according to ...

Biosensors announces enrolment of first patient in REFORM pivotal trial

Biosensors announced today the enrolment of the first patient in REFORM—a prospective, randomised, n...

Survey reveals patient attitudes to heart valve procedures

A US survey released by patient advocacy group Heart-Valve-Surgery.com, with support by Medtronic, h...

InnovHeart secures US$24 million finance package

InnovHeart—developer of novel transcatheter mitral valve replacement (TMVR) systems for the treatmen...

JAHA retracts paper calling for end to cardiology diversity programmes

The Journal of the American Heart Association (JAHA) has retracted a paper published in March 2020, ...

FORWARD PRO study of Evolut Pro valve meets safety and efficacy goals

Thirty-day clinical outcomes from the FORWARD PRO international study of the Evolut Pro (Medtron...

CardioMech secures financing for mitral valve repair study

CardioMech, developer of a transfemoral, transseptally delivered mitral valve repair technology, ann...

Meta-analysis advocates “personalised approach” to DAPT duration after PCI

A meta-analysis of 24 randomised controlled trials assessing dual antiplatelet therapy (DAPT) af...

Eko and AstraZeneca announce digital cardiovascular health partnership

Eko has announced a collaboration with AstraZeneca to accelerate the development of digital health t...

FDA issues EUA for left-sided Impella to provide left ventricular unloading

The US Food and Drug Administration (FDA) has issued an emergency use authorisation (EUA) for le...

Tailoring therapy and maximising TAVI programme efficiency

In this educational supplement, sponsored by Boston Scientific, Cardiovascular News explores the use...

Using remote learning to improve high-risk PCI outcomes

As interventional cardiology continues to grow with higher risk patients and more complex corona...

Frankfurt study finds high rate of cardiac complications in recovered COVID-19 patients

A German study of recently-recovered COVID-19 patients examined using magnetic resonance imaging (MR...

Japanese study finds high survival rates with use of Impella heart pump

A three-year, investigator-led, prospective study of Japanese patients who received an Impella h...

Low one-year rate of mortality found in mitral valve-in-valve replacement using Sapien 3

Sapien 3
One-year outcomes of mitral valve-in-valve replacement using the Sapien 3 (Edwards Lifesciences)...

Keystone Heart announces first case using TriGUARD 3 CEP device

Keystone Heart has announced completion of the first worldwide commercial case using the TriGUAR...

NSAIDs increase bleeding risk after myocardial infarction, Korean study finds

Use of non-steroidal anti-inflammatory drugs (NSAIDs) to treat first-time heart attack patients sign...

American College of Cardiology to launch JACC: Asia

The American College of Cardiology (ACC) is expanding its JACC family of peer-reviewed journals to i...

Abiomed gains approval for data streaming from the Impella console

The US Food and Drug Administration (FDA) has approved one-way digital data streaming during pat...

TAVI or surgical valve replacement “similarly effective” in men and women

Aortic valve replacement, using either transcatheter aortic valve implantation (TAVI) or surgica...

Caption Health gains FDA approval for updates to its cardiac AI system

Caption Health, a developer of medical artificial intelligence (AI) technology, has received US ...

Mavacamten granted Breakthrough Therapy Designation

MyoKardia has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Ther...

Funding secured to further study of AI systems for cardiovascular health

Digital health and artificial intelligence (AI) company Eko has been awarded a US$2.7 million Small ...

Genetic testing could aid decision-making in cardiovascular healthcare

Genetic testing and counselling for inherited cardiovascular diseases may help patients and thei...

Race and gender bias may impact the timing of treatment for heart failure patients

Findings of a US investigation of clinician race and gender bias in decision-making around heart...

Inspiron sirolimus eluting stent receives CE mark approval

Scitech has announced that the Inspiron coronary sirolimus eluting stent has received CE mark approv...

Next-generation Watchman LAAC device gains US FDA approval

Boston Scientific has received US Food and Drug Administration (FDA) approval for the Watchman F...

LifeSignals receives US FDA clearance for the ECG Remote Monitoring Patch

LifeSignals Group has announced that it has received US Food and Drug Administration (FDA) 510(k) cl...

LivaNova launches Perceval Plus sutureless heart valve in Europe

LivaNova has announced that the advanced Perceval Plus sutureless surgical aortic heart valve is now...

Women taking beta blockers for hypertension may have higher risk of heart failure with acute coronary syndrome

Women taking beta blockers for hypertension with no prior history of cardiovascular disease have a n...

Fall in hospitalisations for acute coronary syndrome seen during COVID-19

A rise in the number of out-of-hospital cardiac arrests (OHCAs) correlated with a fall in the number...

FDA approval for Edwards Lifesciences’ KONECT RESILIA aortic valved conduit

Edwards Lifesciences has announced approval from the US Food and Drug Administration (FDA) for t...

AHA Scientific Sessions 2020 to be held virtually

The American Heart Association (AHA) has announced that its 2020 Scientific Sessions will be present...

Half of COVID-19 patients receiving echocardiograms show heart abnormalities

Around half of COVID-19 patients who received an echocardiogram in-hospital showed abnormalities in ...

FDA grants Breakthrough Device Designation for Doraya temporary catheter

Revamp Medical has announced that the US Food and Drug Administration (FDA) has granted Breakthrough...

ACIST Medical Systems announces launch of Navvus II Rapid Exchange FFR microcatheter

ACIST Medical Systems has announced the global launch of its ACIST Navvus II Rapid Exchange FFR Micr...

Venus Medtech and Pi-Cardia to bring Leaflex catheter to Chinese market

Venus Medtech has announced a collaboration to bring Pi-Cardia's Leaflex technology to China. ...

Carag Bioresorbable Septal Occluder approved for US IDE trial

US Food and Drug Administration (FDA) Investigational Device Exemption (IDE) approval has been g...

PCR e-Course 2020: Roll-in trial finds high device success rate for Amplatzer Amulet occlusion device

Left atrial appendage occlusion (LAAO) using the Amplatzer Amulet (Abbott) device has a high imp...

PCR e-Course 2020: Left atrial appendage occlusion improves clinical outcomes vs NOACs in high risk AF patients

Left atrial appendage occlusion (LAAO) improves clinical outcomes including ischaemic stroke, ma...

Smartphone app uses can identify lung congestion in heart failure patients

Voice analysis by a smartphone app can identify lung congestion in heart failure patients, allowing ...

Philips gains FDA clearance for the use of its ultrasound portfolio to manage COVID-19 cardiac complications

Royal Philips has announced that it has received 510(k) clearance from the US Food and Drug Admi...

FDA approves update to cardiac imaging system to aid COVID-19 diagnostics

The US Food and Drug Administration (FDA) has expedited clearance of an update to software from ...

Boston Scientific announces positive PINNACLE FLX study results

Boston Scientific has announced positive 12-month results from the PINNACLE FLX clinical trial a...

LifeSignals receives CE mark for the ECG Remote Monitoring Patch

LifeSignals has received CE mark approval for the LifeSignals ECG Remote Monitoring Patch, a dis...

iRhythm offers home enrolment of Zio monitoring devices

iRhythm Technologies has announced a virtual platform to support patients and clinicians in the ...

US heart societies express concern over using hydroxychloroquine and azithromycin for COVID-19

Presidents of leading cardiac organisations, including the American Heart Association (AHA), the Ame...

Webinar: Cardiovascular specialists detail COVID-19 strategies

Cardiovascular specialists from across the globe shared current knowledge and key experience of ...

AHA issues oxygenation and ventilation guidance for healthcare providers

The American Heart Association (AHA), in conjunction with the American Association for Respirato...

Athena Poppas begins ACC presidency

Athena Poppas (Providence, USA) is the new president of the American College of Cardiology (ACC)...

Cardiologists share COVID-19 insights

Cardiologists from across Europe have shared their experience of having treated COVID-19 patients, i...

Virtual ACC: Mavacamten “promising” in treatment of non-obstructive hypertrophic cardiomyopathy

Results from the phase 2 MAVERICK-HCM clinical trial, presented at the American College of Cardi...

Virtual ACC: Medtronic shares positive results of Onyx ONE Clear Study

Onyx One Clear Study
Medtronic today announced positive results of the Onyx ONE Clear Study that evaluated the Resolu...

Virtual ACC: High success rate for TAVI in bicuspid aortic stenosis patients

Transcatheter aortic valve implantation (TAVI) procedures had a high rate of success and low ris...

AHA commits US$2.5 million for fast-tracked COVID-19 heart and brain research

The American Heart Association (AHA) has committed US$2.5 million to research efforts to better unde...

Append Medical share clinical proof-of-concept results for internal sealing of LAA

Append Medical, developer of the Appligator, a novel left atrial appendage (LAA) closure device ...

VitalConnect adds arrhythmia detection to its remote monitoring software

VitalConnect has announced the introduction of arrhythmia detection to its remote monitoring por...

AI-guided cardiac imaging system given FDA authorisation

The US Food and Drug Administration (FDA) has authorised marketing of software to assist in the acqu...

First patient enrolled in PREDICT-LAA clinical trial

FEops has announced that the first patient has been enrolled in the physician-initiated PREDICT-LAA ...

ACC makes senior staff appointments

The American College of Cardiology (ACC) has announced several promotions and structural changes wit...

FDA grants Breakthrough designation for ECG-based algorithm

The US Food and Drug Administration has granted Breakthrough Device designation to the digital h...

European trial data ‘reinforce’ safety profile and efficacy of Lixiana

The results of the safety profile and efficacy of Lixiana study
Daiichi Sankyo Europe has announced outcomes from an observational study in mainly caucasian atrial ...

AHA 2019: Endotronix shares data from in-human trial of Cordella pulmonary artery pressure sensor

Endotronix has presented first-in-human data of the Cordella pulmonary artery pressure sensor Sy...

Left atrial appendage closure associated with a decreased stroke risk in AF patients

Left atrial appendage closure (LAAC) via implanted device was associated with a decreased risk o...

Alain Cribier

Professor Alain Cribier is a pioneer in the field of aortic and mitral valvuloplasty and has been re...